Effect of Aromatherapy on the Management of Chemotherapy-Induced Neuropathy (CIN)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorCentre Hospitalier de Colmar
About this trial
The main objective of this study is to describe the effect of an essential oil-based blend applied topically in the management of painful symptoms, sensory disturbances, or functional impairment caused by Chemotherapy-Induced Neuropathy (CIN) in breast cancer patients who have undergone paclitaxel treatment.
Eligibility criteria
Qualifiers
Female patients with breast cancer
who have painful or bothersome CIN
occurring in the context of paclitaxel treatment (during or after treatment)
for whom conventional drug treatments provide insufficient relief (or are poorly tolerated or refused).
Disqualifiers
Pre-existing neuropathy (e.g., due to diabetes)
Known allergy to an essential oil or a component of essential oils (e.g., linalool)
Presence of wounds on the affected areas
Refusal to use aromatherapy
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov